Protective effect of melatonin on cigarette smoke-induced restenosis in rat carotid arteries after balloon injury

Journal of Pineal Research

Volumn 57, Issue 4, 2014, Pages 451-458

  Yang, Gen Huan ^a   Li, Yan Chuan ^b   Wang, Zhan Qi ^a   Liu, Bao ^a   Ye, Wei ^a   Ni, Leng ^a   Zeng, Rong ^a   Miao, Shi Ying ^b   Wang, Lin Fang ^b   Liu, Chang Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Cigarette smoke; Inflammation; Melatonin; Restenosis; Vasculature

Indexed keywords

CIGARETTE SMOKE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; MELATONIN; NALOXONE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON INDUCED CAROTID ARTERY INJURY; CAROTID ARTERY; CAROTID ARTERY INJURY; CAROTID ARTERY OBSTRUCTION; CELL INFILTRATION; CIGARETTE SMOKE INDUCED CAROTID ARTERY RESTENOSIS; CONTROLLED STUDY; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; LIPOPHILICITY; MALE; NONHUMAN; RAT; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; CAROTID STENOSIS; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECURRENT DISEASE; SMOKE; SPRAGUE DAWLEY RAT; TOBACCO;

ANGIOPLASTY, BALLOON; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CAROTID ARTERIES; CAROTID STENOSIS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; SMOKE; TOBACCO;

EID: 84919386896     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12185     Document Type: Article

References (47)

1. GRUNTZIG AR, SENNING A, SIEGENTHALER WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301:61-68.
2. WU L, ZHU L, SHI WH et al. Zoledronate inhibits intimal hyperplasia in balloon-injured rat carotid artery. Eur J Vasc Endovasc Surg 2011; 41:288-293.
3. SERRUYS PW, de JAEGERE P, KIEMENEIJ F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331:489-495.
4. FISCHMAN DL, LEON MB, BAIM DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331:496-501.
5. CHAN RC, CHAN YC, CHEUNG GC et al. Predictors of restenosis after carotid endarterectomy: 17-year experience in a tertiary referral vascular center. Vasc Endovascular Surg 2014; 48:201-206.
6. CHEN J, CHEN Y, TIAN F et al. Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation. Zhonghua Xin Xue Guan Bing Za Zhi 2014; 42:14-18.
7. GALAN KM, DELIGONUL U, KERN MJ et al. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988; 61:260-263.
8. van DIJK WD, AKKERMANS R, HEIJDRA Y et al. The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients. Biomark Med 2013; 7:211-219.
9. ARNSON Y, SHOENFELD Y, AMITAL H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34:258-265.
10. BLANN AD, SEIGNEUR M, STEINER M et al. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost 1998; 79:1080-1085.
11. ALVAREZ LR, BALIBREA JM, SURINACH JM et al. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease. Eur J Prev Cardiol 2013; 20:486-495.
12. KORKMAZ A, REITER RJ, TOPAL T et al. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009; 15:43-50.
13. REITER RJ, PAREDES SD, MANCHESTER LC et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44:175-200.
14. ZHANG HM, ZHANG Y. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57:131-146.
15. GALLEY HF, LOWES DA, ALLEN L et al. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res 2014; 56:427-438.
16. MAURIZ JL, COLLADO PS, VENEROSO C et al. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
17. REITER RJ, CALVO JR, KARBOWNIK M et al. Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 2000; 917:376-386.
18. MENENDEZ-PELAEZ A, REITER RJ. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 1993; 15:59-69.
19. REITER RJ, TAN DX, ROSALES-CORRAL S et al. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini RevMed Chem 2013; 13:373-384.
20. HUNG MW, KRAVTSOV GM, LAU CF et al. Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia. J Pineal Res 2013; 55:247-256.
21. HU ZP, FANG XL, FANG N et al. Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-kappaB system in highfat-fed rabbits. J Pineal Res 2013; 55:388-398.
22. DUAN W, YANG Y, YI W et al. New role of JAK2/STAT3 signaling in endothelial cell oxidative stress injury and protective effect of melatonin. PLoS ONE 2013; 8:e57941.
23. RODELLA LF, FILIPPINI F, BONOMINI F et al. Beneficial effects of melatonin on nicotine-induced vasculopathy. J Pineal Res 2010; 48:126-132.
24. HAUTAMAKI RD, KOBAYASHI DK, SENIOR RM et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277:2002-2004.
25. TULIS DA, DURANTE W, LIU X et al. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 2001; 104:2710-2715.
26. SHIMOSATO T, GEDDAWY A, TAWAMet al. Chronic administration of nicotine-free cigarette smoke extract impaired endothelium-dependent vascular relaxation in rats via increased vascular oxidative stress. J Pharmacol Sci 2012; 118:206-214.
27. THIELEN A, KLUS H, MULLER L. Tobacco smoke: unraveling a controversial subject. Exp Toxicol Pathol 2008; 60:141-156.
28. BORGERDING M, KLUS H. Analysis of complex mixtures-cigarette smoke. Exp Toxicol Pathol 2005; 57:43-73.
29. BRAUN KF, EHNERT S, FREUDE T et al. Quercetin protects primary human osteoblasts exposed to cigarette smoke through activation of the antioxidative enzymes HO-1 and SOD-1. Sci World J 2011; 11:2348-2357.
30. BORGERDING M, KLUS H. Analysis of complex mixtures-cigarette smoke. Exp Toxicol Pathol 2005; 57(Suppl 1):43-73.
31. SINGH M, JADHAV HR. Melatonin: functions and ligands. Drug Discov Today 2014; 19:1410-1418.
32. WANG Y, LIU X, WANG W et al. The expression of inflammatory cytokines on the aorta endothelia are up-regulated in pinealectomized rats. Inflammation 2013; 36:1363-1373.
33. UENO H, PRADHAN S, SCHLESSEL D et al. Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1. Cardiovasc Toxicol 2006; 6:39-50.
34. YAMASAKI K, ASAI T, SHIMIZU M et al. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine ballooninjured coronary artery model. Gene Ther 2003; 10:356-364.
35. YOSHIMURA S, MORISHITA R, HAYASHI K et al. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy. Gene Ther 2001; 8:1635-1642.
36. OHTANI K, EGASHIRA K, NAKANO K et al. Stent-based local delivery of nuclear factor-jB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits. Circulation 2006; 114:2773-2779.
37. GRASSIA G, MADDALUNO M, MUSILLI C et al. The IjB kinase inhibitor nuclear factor-jB essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2010; 30:2458-2466.
38. GONCALVES RB, COLETTA RD, SILVERIO KG et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res 2011; 60:409-424.
39. TSIARA S, ELISAF M, MIKHAILIDIS DP. Influence of smoking on predictors of vascular disease. Angiology 2003; 54:507-530.
40. YANBAEVA DG, DENTENER MA, CREUTZBERG EC et al. Systemic effects of smoking. Chest 2007; 131:1557-1566.
41. GALANO A, TAN DX, REITER RJ. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54:245-257.
42. NATHAN C, XIE QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78:915-918.
43. FARACI FM, SIGMUND CD. Vascular biology in genetically altered mice : smaller vessels, bigger insight. Circ Res 1999; 85:1214-1225.
44. SU Y, HAN W, GIRALDO C et al. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998; 19:819-825.
45. HIGMAN DJ, STRACHAN AM, BUTTERY L et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 1996; 16:546-552.
46. RODELLA LF, FAVERO G, ROSSINI C et al. Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. Life Sci 2010; 87:558-564.
47. INDOLFI C, TORELLA D, COPPOLA C et al. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circ Res 2002; 91:1190-1197.